Interactions between transderm-nitro(nitroglycerin) and Activase (alteplase)
nitroglycerin and alteplase (Moderate Drug-Drug)
MONITOR: Limited data suggest that average plasma tPA levels and tPA-induced thrombolysis may be significantly reduced in the presence of nitroglycerin. The mechanism is not known, but may be due to nitroglycerin-induced increases in hepatic blood flow, which may result in increased hepatic metabolism of tPA. Isosorbide may theoretically also have an effect.
MANAGEMENT: While more data are needed, clinicians are warned of the possibility of decreased effectiveness of alteplase when these drugs are given together.